Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
<p>Abstract</p> <p>Background</p> <p>There is increasing evidence that the presence of an ongoing systemic inflammatory response is associated with poor prognosis in patients with advanced cancers. We evaluated the relationships between clinical status, laboratory facto...
Main Authors: | Hwang Jun-Eul, Kim Ha-Na, Kim Dae-Eun, Choi Hyun-Jung, Jung Sung-Hoon, Shim Hyun-Jeong, Bae Woo-Kyun, Hwang Eu-Chang, Cho Sang-Hee, Chung Ik-Joo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/489 |
Similar Items
-
Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
by: Sun Kyung Baek, et al.
Published: (2019-11-01) -
Novel Palliative Chemotherapy in Patients with Metastatic Pancreatic Cancer: PEGPH20
by: Dong Uk Kim
Published: (2018-04-01) -
Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study
by: Jung Sun Kim, et al.
Published: (2018-12-01) -
A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting
by: Ka-Rham Kim, et al.
Published: (2015-01-01) -
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung
by: Yoon Jung Jang, et al.
Published: (2021-06-01)